Evidence map›Paper›PMID 38765943›Full record

ArticlePsychiatry and clinical psychopharmacology2021

Peripheral Expression of

Alper Alnak, İpek Kuşcu Özücer, Ahmet Okay Çağlayan, Murat Coşkun

Abstract read
In one paragraph

Article in Psychiatry and clinical psychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Peripheral Expression ofPsychiatry and clinical psychopharmacology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alper AlnakDepartment of Child and Adolescent Psychiatry, Istanbul University School of Medicine, Istanbul, Turkey.ORCID 0000-0002-3515-8217
İpek Kuşcu ÖzücerDepartment of Child and Adolescent Psychiatry, Istanbul University School of Medicine, Istanbul, Turkey.
Ahmet Okay ÇağlayanDepartment of Medical Genetics, Dokuz Eylul University School of Medicine, Izmir, Turkey.ORCID 0000-0002-2332-322X
Murat CoşkunDepartment of Child and Adolescent Psychiatry, Istanbul University School of Medicine, Istanbul, Turkey.ORCID 0000-0002-4808-5870

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Genomic variations in mono-ADP ribosylhydrolase 2 ( Methods: The study group included 100 children with a DSM-5 diagnosis of ASD, and the control group consisted of 105 healthy controls. Blood samples were obtained from all participants in this study, and the gene expression level was determined using quantitative reverse transcription PCR (RT-qPCR). Statistical analysis was performed with R 3.4.0 and Statistical Program for Social Sciences (SPSS for Windows, 21.0). Results: The mean ages of the participants in the study and control groups were 9.22 ± 3.62 and 9.27 ± 3.86 years, respectively. There was no significant difference concerning gender ( Conclusions: This is the first study in the literature investigating the peripheral expression of the

Indexed as

AutismexpressionfamilygeneticsMACROD2macro domain

Identifiers

PMID38765943
PMCPMC11079661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.